Cyril Amarchand Mangaldas advises Biocon on the deal. Biocon Limited (Biocon) executed the sale of shares of Syngene International Limited (Syngene International) by Biocon, with a reported...
Biocon’s Share Sale in Syngene International
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Serum Institute Life Sciences’ Acquisition of 15% Stake in Biocon Biologics
Shardul Amarchand Mangaldas & Co. and Krishnamurthy & Co. advised Biocon Biologics on the deal, while Veritas Legal advised Serum Institute Life Sciences. Biocon Biologics Limited...